Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on immune & genetic health. Browse all Immune & Genetic Health education

The IL-23R gene encodes a receptor that sits at a decision point in the immune system — the switch that helps determine how aggressively your body mounts inflammation. Small inherited differences in this gene have been linked, across large population studies, to the risk of several autoimmune and inflammatory conditions. Understanding what IL-23R does, and what the common variants mean, is a useful lens on your own immune biology.

What IL-23R Does in the Immune System

IL-23R is the receptor for interleukin-23 (IL-23), a signaling protein that activates a specialized group of immune cells. When IL-23 binds its receptor on the surface of these cells, it drives the maturation and survival of Th17 cells — a subset of T-helper cells named for the interleukin-17 (IL-17) they produce.

Th17 cells are protective in the right context. They defend mucosal surfaces — the gut lining, the skin, the airways — against fungi and certain bacteria. The problem is balance. When the IL-23/Th17 axis runs too hot, the same cells that guard those barriers can drive chronic inflammation and attack the body's own tissue. IL-23R is the throttle on that system, which is why variation in the gene matters.

The R381Q Variant (rs11209026) and Why It Matters

The most studied IL-23R variant is rs11209026, a single-nucleotide change that swaps arginine for glutamine at position 381 of the protein — written R381Q or Arg381Gln. This variant partially dampens IL-23 signaling, and it is one of the more consistent protective signals in autoimmune genetics.

Carriers of the minor (A) allele show measurably reduced Th17 activity in laboratory studies. Because that pathway is a driver of several inflammatory diseases, the same variant that quiets it has been associated with lower risk of conditions such as inflammatory bowel disease, psoriasis, and ankylosing spondylitis. It is a rare example of a common variant that appears to shift the immune dial toward calm.

IL-23R and Autoimmune Conditions: What the Research Shows

Genome-wide association studies first flagged IL-23R in Crohn's disease and ulcerative colitis, then found overlapping signals in psoriasis, psoriatic arthritis, and ankylosing spondylitis. That cross-condition pattern is the point: these diseases look different in the clinic but share the IL-23/Th17 pathway underneath. A variant that changes signaling upstream can nudge risk across the whole family of conditions.

This shared architecture also explains why a class of biologic medications targeting IL-23 or IL-17 works across multiple diagnoses. The genetics and the pharmacology converge on the same pathway — though whether any specific therapy is appropriate is a clinical decision, not a genetic one.

One Gene, Many Downstream Effects

IL-23R does not act alone. Its effect depends on other genes in the pathway — including IL12B, which encodes a subunit shared by IL-23, and the IL-17 genes downstream. This is why immune predisposition is best read as a pathway, not a single result. Two people can carry the same IL-23R genotype and express very different immune tendencies because the rest of their genetic and environmental context differs.

What Pathway-Level Genetic Insight Adds

A genetic variant is context, not a verdict. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across peptide-related biological pathways — mapping variants that shape inflammation, immune signaling, and repair. It reads your baseline biology at the pathway level. It does not diagnose an autoimmune condition, and it does not tell you whether you will develop one.

The governing idea is simple: PlexusDx tells you about your biology. It does not tell you what to put in your body. Knowing that an IL-23/Th17 tendency runs in your profile is a starting point for a more informed conversation — not a diagnosis and not a treatment plan.

Working With a Qualified Provider

If you live with symptoms of an inflammatory or autoimmune condition — persistent joint pain, gut symptoms, skin changes — the right next step is a licensed healthcare provider who can evaluate, test, and, where appropriate, treat. Genetic insight can inform that discussion by adding pathway context, but diagnosis and management belong in clinical hands.

Frequently Asked Questions

Does the IL-23R gene cause autoimmune disease?

No single gene causes autoimmune disease. IL-23R variants shift the probability by influencing IL-23/Th17 immune signaling, but risk reflects many genes plus environment. The R381Q variant (rs11209026) is actually associated with lower risk. Genetics describes tendencies, not certainties, and a provider evaluates any actual condition.

What is the R381Q variant of IL-23R?

R381Q, tracked by rs11209026, is a common IL-23R variant that swaps one amino acid and partially reduces IL-23 signaling. Because it dampens the Th17 inflammatory pathway, carriers show a modestly lower risk of several autoimmune conditions in large population studies. It is a protective signal, not a guarantee.

Can a genetic test diagnose an autoimmune disorder?

No. Genetic testing describes pathway-level tendencies in immune biology; it does not diagnose disease. Diagnosis requires clinical evaluation, symptoms, and laboratory work interpreted by a licensed provider. The PlexusDx test offers educational context about immune and inflammatory pathways, not a medical diagnosis or a treatment recommendation.

Can I change how my IL-23R gene behaves?

You cannot change your genotype, but gene expression and immune tone respond to context — sleep, stress, diet, infection, and medical care all shape inflammation. Pathway-level insight helps you and your provider understand your starting point so lifestyle and clinical decisions are made with more information, not less.

Curious how your own immune and inflammatory pathways are built? Take the Precision Peptide Genetic Test to see your pathway-level genetic insights.

This article is part of the PlexusDx Education Hub. Browse all Immune & Genetic Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.